Stock listing

NASDAQ:GWPH GW Pharmaceuticals plc Stock

Follow GW Pharmaceuticals plc into a list and get an email when it puts out news.

Last close · NASDAQ:GWPH

$218.96 USD

Close on May 5, 2021 · No longer trades

May 1, 2013 to last close +2,338% · weekly closes, May 1, 2013 – May 5, 2021
Lowest – highest close
$8.51 – $219.28 USDSince May 1, 2013 · lowest Jun 11, 2013 · highest May 3, 2021

Delisted NASDAQ:GWPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GWPH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

GW Pharmaceuticals plc on 6ix

Decks
11 decks · latest Feb 26, 2021

Decks

DeckKindSlidesDate
Merger or Acquisition (February 2021)Merger or acquisition12 slidesFeb 26, 2021
FY2020 Earnings PresentationEarnings10 slidesFeb 23, 2021
Merger or Acquisition (February 2021)Merger or acquisition21 slidesFeb 4, 2021
Shareholder Meeting (June 2019)Shareholder meeting28 slidesJun 13, 2019
37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference23 slidesJan 7, 2019
Shareholder Meeting (March 2018)Shareholder meeting33 slidesMar 14, 2018
Technical Presentation (December 2017)Technical24 slidesDec 4, 2017
Shareholder Meeting (March 2017)Shareholder meeting35 slidesMar 14, 2017
Investor Presentation (January 2017)Investor deck33 slidesJan 9, 2017
Investor Day (October 2014)Investor day118 slidesOct 15, 2014
All 11 decks
DeckKindSlidesDate
Technical Presentation (June 2014)Technical12 slidesJun 17, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alicia Secor
Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past)
Director · Oct 1, 2018 – May 5, 2021 · Past
Justin Gover
Other companies: Design Therapeutics, Inc. (Director · Since at least Sep 9, 2025); COMPASS Pathways Plc (INDEPENDENT DIRECTOR · Since at least Jul 29, 2025); Xenon Pharmaceuticals Inc. (Director · Since at least Aug 8, 2023)
Chief Executive Officer, Director · Oct 1, 2018 – May 5, 2021 · Past
James Noble
Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2022 · Past)
Director · Oct 1, 2018 – May 5, 2021 · Past
Douglas B. Snyder
Other companies: IDEAYA Biosciences, Inc. (Chief Legal Officer · Since at least Sep 18, 2024)
Chief Legal Officer · Oct 1, 2018 – May 5, 2021 · Past
Scott Giacobello
Other companies: Whitehawk Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 28, 2021)
Chief Financial Officer · Oct 1, 2018 – May 5, 2021 · Past
Volker Knappertz
Other companies: Aurinia Pharmaceuticals Inc (EVP, Research and Development · Jul 18, 2022 – Feb 27, 2024 · Past)
Chief Medical Officer · Oct 1, 2018 – May 5, 2021 · Past
Geoffrey W Dr GuyExecutive Chairman, Director · Oct 1, 2018 – May 5, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about GW Pharmaceuticals plc.